1. Frost J K, Ball W C Jr, Levin M L, et al. Early Lung Cancer Detection: Results of the Initial (Prevalence) Radiologic and Cytologic Screening in The Johns Hopkins Study[J]. Am Rev Resp Dis, 1984, 130: 549–554.
2. Brambilla C, Fievet F, Jeanmart M, et al. Early Detection of Lung Cancer: Role of Biomarkers[J]. Eur Respir J, 2003, 39: 36s–44s.
3. Shih C M, Chen K, Wang Y C, et al. Elevated p53 and p21waf1 mRNA Expression in Blood Lymphocytes from Lung Cancer Patients with Chemoresistance[J]. Cancer Detect Prev, 2007, 31: 366–370.
4. Liu W S, Gao S H, Wang M, et al. Detection of p53 Gene Mutation in Serum of Patients with Lung Cancer and Its Clinical Value[J]. Chin J Pathol, 2008, 37: 406–407(Ch).
5. Rusch V, Klimstra D, Linkov I, et al. Aberrant Expression of p53 or the Epidermal Growth Factor Receptor is Frequent in Early Bronchial Neoplasia, and Coexpression Precedes Squamous Cell Carcinoma Development[J]. Cancer Res, 1995, 55: 1 365–1 372.